Skip to main content
SpringerLink
Log in

Decreased T2 signal in the thalami may be a sign of lysosomal storage disease

  • Paediatric Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Introduction

Lysosomal disorders are rare and are caused by genetically transmitted lysosomal enzyme deficiencies. A decreased T2 signal in the thalamus has occasionally been reported.

Aims

Because the finding of bilateral abnormal signal intensity of the thalamus on T2-weighted images has not been systematically reviewed, and its value as a diagnostic tool critically evaluated, we carried out a systematic review of the literature.

Methods

Articles in English with 30 trios of keywords were collected from PubMed. Exclusion criteria were lack of conventional T2-weighted images in the protocol and not being a human study. Finally, 111 articles were included. The thalamus was considered affected only if mentioned in the text or in the figure legends.

Results

Some 117 patients with various lysosomal diseases and five patients with ceruloplasmin deficiency were reported to have a bilateral decrease in T2 signal intensity. At least one article reported a bilateral decrease in signal intensity of the thalami on T2-weighted images in association with GM1 and GM2 gangliosidosis and with Krabbe’s disease, aspartylglucosaminuria, mannosidosis, fucosidosis, and mucolipidosis IV. Furthermore, thalamic alteration was a consistent finding in several types of neuronal ceroid lipofuscinosis (NCL) including CLN1 (infantile NCL), CLN2 (classic late infantile NCL), CLN3 (juvenile NCL), CLN5 (Finnish variant late infantile NCL), and CLN7 (Turkish variant late infantile NCL).

Conclusion

A decrease in T2 signal intensity in the thalami seems to be a sign of lysosomal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Agamanolis D (2005) Metabolic and toxic disorders. In: Prayson R, Goldblum J (eds) Neuropathology. Elsevier Churchill Livingstone, Philadelphia, pp 339–372

    Google Scholar 

  2. Pastores GM, Kolodny EH (2006) Lysosomal storage diseases. In: Swaiman KF, Ashwall S, Ferriero DM (eds) Pediatric neurology: principles and practice. Mosby Elsevier, Philadelphia, pp 659–714

    Google Scholar 

  3. Autti T, Raininko R, Vanhanen S-L, Kallio M, Santavuori P (1994) MRI of the normal brain from early childhood to middle age. I Appearances on T2- and proton density-weighted images and occurrence of incidental high-signal foci. Neuroradiology 36:644–648

    Article  PubMed  CAS  Google Scholar 

  4. Autti T, Raininko R, Vanhanen S-L, Kallio M, Santavuori P (1994) MRI of the normal brain from early childhood to middle age. II. Age dependence of signal intensity changes on T2-weighted images. Neuroradiology 36:649–651

    Article  PubMed  CAS  Google Scholar 

  5. Barkovich AJ (ed) (2005) Pediatric neuroimaging. Lippincott Williams & Wilkins, Philadelphia, pp 76–189

    Google Scholar 

  6. Morita H, Ikeda S, Yamamoto K et al (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 37:646–656

    Article  PubMed  CAS  Google Scholar 

  7. Hatanaka Y, Okano T, Oda K, Yamamoto K, Yoshida K (2003) Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. Intern Med 42:599–604

    PubMed  Google Scholar 

  8. Yonekawa M, Okabe T, Asamoto Y, Ohta M (1998) A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma. Eur Neurol 42:157–162

    Article  Google Scholar 

  9. Al-Essa MA, Bakheet SM, Patay ZJ, Nounou RM, Ozand PT (1999) Cerebral fuorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI, and clinical observations in a patient with infantile G(M1) gangliosidosis. Brain Dev 21:559–562

    Article  PubMed  CAS  Google Scholar 

  10. Chen CY, Zimmerman RA, Lee CC, Chen FH, Yuh YS, Hsiao HS (1998) Neuroimaging findings in late infantile GM1 gangliosidosis. AJNR Am J Neuroradiol 19:1628–1630

    PubMed  CAS  Google Scholar 

  11. Kobayashi O, Takashima S (1994) Thalamic hyperdensity on CT in infantile GM1-gangliosidosis. Brain Dev 16:472–474

    Article  PubMed  CAS  Google Scholar 

  12. Aydin K, Bakir B, Tatli B, Terzibasioglu E, Ozmen M (2005) Proton MR spectroscopy in three children with Tay-Sachs disease. Pediatr Radiol 35:1081–1085

    Article  PubMed  Google Scholar 

  13. Grosso S, Farnetani MA, Berardi R et al (2003) GM2 gangliosidosis variant B1 neuroradiological findings. J Neurol 250:17–21

    Article  PubMed  Google Scholar 

  14. Mugikura S, Takahashi S, Higano S, Kurihara N, Kon K, Sakamoto K (1996) MR findings in Tay-Sachs disease. J Comput Assist Tomogr 20:551–555

    Article  PubMed  CAS  Google Scholar 

  15. Yun YM, Lee SN (2005) A case report of Sandhoff disease. Korean J Ophthalmol 19:68–72

    Article  PubMed  Google Scholar 

  16. Yuksel A, Yalcinkaya C, Islak C, Gunduz E, Seven M (1999) Neuroimaging findings of four patients with Sandhoff disease. Pediatr Neurol 21:562–565

    Article  PubMed  CAS  Google Scholar 

  17. Hittmair K, Wimberger D, Bernert G, Mallek R, Schindler EG (1996) MRI in a case of Sandhoff’s disease. Neuroradiology 38 [Suppl 1]:S78–S80

    Google Scholar 

  18. Caliskan M, Ozmen M, Beck M, Apak S (1993) Thalamic hyperdensity – is it a diagnostic marker for Sandhoff disease. Brain Dev 15:387–388

    Article  PubMed  CAS  Google Scholar 

  19. Koelfen W, Freund M, Jaschke W, Koenig S, Schultze C (1994) GM-2 gangliosidosis (Sandhoff’s disease): two year follow-up by MRI. Neuroradiology 36:152–154

    Article  PubMed  CAS  Google Scholar 

  20. Zafeiriou DI, Anastasiou AL, Michelakaki EM, Augoustidou-Savvopoulou PA, Katzos GS, Kontopoulos EE (1997) Early infantile Krabbe disease: deceptively normal magnetic resonance imaging and serial neurophysiological studies. Brain Dev 19:488–491

    Article  PubMed  CAS  Google Scholar 

  21. Zafeiriou DI, Michelakaki EM, Anastasiou AL, Gombakis NP, Kontopoulos EE (1996) Serial MRI and neurophysiological studies in late-infantile Krabbe disease. Pediatr Neurol 15:240–244

    Article  PubMed  CAS  Google Scholar 

  22. Vanhanen SL, Raininko R, Santavuori P (1994) Early differential diagnosis of infantile neuronal ceroid lipofuscinosis, Rett syndrome, and Krabbe disease by CT and MR. AJNR Am J Neuroradiol 15:1443–1453

    PubMed  CAS  Google Scholar 

  23. Bernardi B, Fonda C, Franzoni E, Marchiani V, Della Guistina E, Zimmerman RA (1994) MRI and CT in Krabbe’s disease: case report. Neuroradiology 36:477–479

    Article  PubMed  CAS  Google Scholar 

  24. Finelli DA, Tarr RW, Sawyer RN, Horwitz SJ (1994) Deceptively normal MR in early infantile Krabbe disease. AJNR Am J Neuroradiol 15:167–171

    PubMed  CAS  Google Scholar 

  25. Barone R, Bruhl K, Stoeter P, Fiumara A, Pavone L, Beck M (1996) Clinical and neuroradiological findings in classic infantile and late-onset globoid-cell leukodystrophy (Krabbe disease). Am J Med Genet 63:209–217

    Article  PubMed  CAS  Google Scholar 

  26. Percy AK, Odrezin GT, Knowles PD, Rouah E, Armstrong DD (1994) Globoid cell leukodystrophy: comparison of neuropathology with magnetic resonance imaging. Acta Neuropathol (Berl) 88:26–32

    Article  CAS  Google Scholar 

  27. Autti T, Raininko R, Haltia M et al (1997) Aspartylglucosaminuria: radiologic course of the disease with histopathologic correlation. J Child Neurol 12:369–375

    PubMed  CAS  Google Scholar 

  28. Ara JR, Mayayo E, Marzo ME, Guelbenzu S, Chabas A, Pina MA, Calderon C (1999) Neurological impairment in alpha-mannosidosis: a longitudinal clinical and MRI study of a brother and sister. Childs Nerv Syst 15:369–371

    Article  PubMed  CAS  Google Scholar 

  29. Inui K, Akagi M, Nishigaki T, Muramatsu T, Tsukamoto H, Okada S (2000) A case of chronic infantile type of fucosidosis: clinical and magnetic resonance image findings. Brain Dev 22:47–49

    Article  PubMed  CAS  Google Scholar 

  30. Autti T, Raininko R, Launes J, Nuutila A, Santavuori P (1992) Jansky-Bielschowsky variant disease: CT, MRI and SPECT findings. Pediatric Neurol 8:121–126

    Article  CAS  Google Scholar 

  31. Vanhanen SL, Raininko R, Autti T, Santavuori P (1996) MRI evaluation of the brain in infantile neuronal ceroid lipofuscinosis. Part 2: MRI findings in 21 patients. J Child Neurol 10:444–450

    Article  Google Scholar 

  32. Autti T, Raininko R, Vanhanen SL, Santavuori P (1996) MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroidl lipofuscinosis. Neuroradiology 38:476–782

    PubMed  CAS  Google Scholar 

  33. Topçu M, Tan H, Yalnızoğlu D et al (2004) Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies. Turk J Pediatr 46:1–10

    PubMed  Google Scholar 

  34. Frei KP, Patronas NJ, Crutchfield KE. Altarescu G, Schiffmann R (1998) Mucolipidosis type IV: characteristic MRI findings. Neurology 51:565–569

    PubMed  CAS  Google Scholar 

  35. Inglese M, Nusbaum AO, Pastores GM, Gianutsos J, Kolodny EH, Gonen O (2005) MR imaging and proton spectroscopy of neural injury in late-onset GM2 gangliosidosis. AJNR Am J Neuroradiol 26:2037–2042

    PubMed  Google Scholar 

  36. Gururaj A, Sztriha L, Hertecant, J, Johansen JG, Georgiou T, Campos Y, Drousiotou A, d’Azzo A (2005) Magnetic resonance imaging findings and novel mutations in GM1 gangliosidosis. J Child Neurol 20:57–60

    PubMed  Google Scholar 

  37. Streifler JY, Gornish M, Hadar H, Gadoth N (1993) Brain imaging in late-onset GM2 gangliosidosis. Neurology 43:2055–2058

    PubMed  CAS  Google Scholar 

  38. Uyama E, Terasaki T, Watanabe S, Naito M, Owada M, Araki S, Ando M (1992) Type 3 GM1 gangliosidosis: characteristic MRI findings correlated with dystonia. Acta Neurol Scand 86:609–615

    PubMed  CAS  Google Scholar 

  39. Fukumizu M, Yoshikawa H, Takashima S, Sakuragawa N, Kurokawa T (1992) Tay-Sachs disease: progression of changes on neuroimaging in four cases. Neuroradiology 34:483–486

    Article  PubMed  CAS  Google Scholar 

  40. Seitz D, Grodd W, Schwab A, Seeger U, Klose U, Nagele T (1998) MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis. AJNR Am J Neuroradiol 19:1373–1377

    PubMed  CAS  Google Scholar 

  41. Choi S, Enzmann DR (1993) Infantile Krabbe disease: complementary CT and MR findings. AJNR Am J Neuroradiol 14:1164–1166

    PubMed  CAS  Google Scholar 

  42. Chang YC, Huang CC, Chen CY, Zimmerman RA (2000) MRI in acute neuropathic Gaucher’s disease. Neuroradiology 42:48–50

    Article  PubMed  CAS  Google Scholar 

  43. Moore DF, Ye F, Schiffmann R, Butman JA (2003) Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. AJNR Am J Neuroradiol 24:1096–1101

    PubMed  Google Scholar 

  44. Politei JM, Capizzano AA (2006) Magnetic resonance image findings in 5 young patients with Fabry disease. Neurologist 12:103–105

    Article  PubMed  Google Scholar 

  45. Gupta S, Ries M, Kotsopoulos S, Schiffmann R (2005) The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women. Medicine (Baltimore) 84:261–268

    Article  CAS  Google Scholar 

  46. Takanashi J, Barkovich AJ, Dillon WP, Sherr EH, Hart KA, Packman S (2003) T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease. AJNR Am J Neuroradiol 24:916–921

    PubMed  Google Scholar 

  47. Morse RP, Kleta R, Alroy J, Gahl WA (2005) Novel form of intermediate salla disease: clinical and neuroimaging features. J Child Neurol 20:814–816

    Article  PubMed  Google Scholar 

  48. Parazzini C, Arena S, Marchetti L et al (2003) Infantile sialic acid storage disease: serial ultrasound and magnetic resonance imaging features. AJNR Am J Neuroradiol 24:398–400

    PubMed  Google Scholar 

  49. Linnankivi T, Lonnqvist T, Autti T (2003) A case of Salla disease with involvement of the cerebellar white matter. Neuroradiology 45:107–109

    PubMed  CAS  Google Scholar 

  50. Sonninen P, Autti T, Varho T, Hamalainen M, Raininko R (1999) Brain involvement in Salla disease. AJNR Am J Neuroradiol 20:433–443

    PubMed  CAS  Google Scholar 

  51. Varho T, Jaaskelainen S, Tolonen U, Sonninen P, Vainionpaa L, Aula P, Sillanpaa M (2000) Central and peripheral nervous system dysfunction in the clinical variation of Salla disease. Neurology 55:99–104

    PubMed  CAS  Google Scholar 

  52. Haataja L, Parkkola R, Sonninen P et al (1994) Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder. Neuropediatrics 25:238–244

    PubMed  CAS  Google Scholar 

  53. Melis D, Parenti G, Della Casa R et al (2004) Brain damage in glycogen storage disease type I. J Pediatr 144:637–642

    Article  PubMed  CAS  Google Scholar 

  54. Gutschalk A, Harting I, Cantz M, Springer C, Rohrschneider K, Meinck HM (2004) Adult alpha-mannosidosis: clinical progression in the absence of demyelination. Neurology 63:1744–1746

    PubMed  CAS  Google Scholar 

  55. Patlas M, Shapira MY, Nagler A, Sheffer R, Gomori JM (2001) MRI of mannosidosis. Neuroradiology 43:941–943

    Article  PubMed  CAS  Google Scholar 

  56. Dietemann JL, Filippi de la Palavesa MM, Tranchant C, Kastler B (1990) MR findings in mannosidosis. Neuroradiology 32:485–487

    Article  PubMed  CAS  Google Scholar 

  57. Galluzzi P, Rufa A, Balestri P, Cerase A, Federico A (2001) MR brain imaging of fucosidosis type I. AJNR Am J Neuroradiol 22:777–780

    PubMed  CAS  Google Scholar 

  58. Ismail EA, Rudwan M, Shafik MH (1999) Fucosidosis: immunological studies and chronological neuroradiological changes. Acta Paediatr 88:224–227

    Article  PubMed  CAS  Google Scholar 

  59. Terespolsky D, Clarke JT, Blaser SI (1006) Evolution of the neuroimaging changes in fucosidosis type II. J Inherit Metab Dis 19:775–781

    Article  Google Scholar 

  60. Provenzale JM, Barboriak DP, Sims K (1995) Neuroradiologic findings in fucosidosis, a rare lysosomal storage disease. AJNR Am J Neuroradiol 16:809–813

    PubMed  CAS  Google Scholar 

  61. Confort-Goyny S, Chabrol B, Vion-Dury J, Mancini J, Cozzone PJ (1993) MRI and localized proton MRS in early infantile form of neuronal ceroid-lipofuscinosis. Pediatr Neurol 9:57–60

    Article  Google Scholar 

  62. Matheus MG, Castillo M, Smith JK, Armao D, Towle D, Muenzer J (2004) Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology 46:666–672

    Article  PubMed  Google Scholar 

  63. Gabrielli O, Polonara G, Regnicolo L, Petroni V, Scarabino T, Coppa GV, Salvolini U (2004) Correlation between cerebral MRI abnormalities and mental retardation in patients with mucopolysaccharidoses. Am J Med Genet 125:224–231

    Article  Google Scholar 

  64. Barone R, Parano E, Trifiletti RR, Fiumara A, Pavone P (2002) White matter changes mimicking a leukodystrophy in a patient with mucopolysaccharidosis: a characterization by MRI. J Neurol Sci 195:171–175

    Article  PubMed  Google Scholar 

  65. Barone R, Nigro F, Triulzi F, Musumeci S, Fiumara A, Pavone L (1999) Clinical and neuroradiological follow-up in mucopolysaccharidosis type III (Sanfilippo syndrome). Neuropediatrics 30:270–274

    Article  PubMed  CAS  Google Scholar 

  66. Hughes DG, Chadderton RD, Cowie RA, Wraith JE, Jenkins JP (1997) MRI of the brain and craniocervical junction in Morquio’s disease. Neuroradiology 39:381–385

    Article  PubMed  CAS  Google Scholar 

  67. Zafeiriou DI, Savvopoulou Augoustidou PA, Sewell A et al (2001) Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo’s syndrome B). Brain Dev 23:385–389

    Article  PubMed  CAS  Google Scholar 

  68. Petitti N, Holder CA, Williams DW 3rd (1997) Mucopolysaccharidosis III (San Filippo syndrome) type B: cranial imaging in two cases. J Comput Assist Tomogr 21:897–899

    Article  PubMed  CAS  Google Scholar 

  69. Shinomiya N, Nagayama T, Fujioka Y, Aoki T (1996) MRI in the mild type of mucopolysaccharidosis II (Hunter’s syndrome). Neuroradiology 38:483–485

    PubMed  CAS  Google Scholar 

  70. Lee C, Dineen TE, Brack M, Kirsch JE, Runge VM (1994) The mucopolysaccharidoses: characterization by cranial MR imaging. AJNR Am J Neuroradiol 14:1285–1292

    Google Scholar 

  71. Parsons VJ, Hughes DG, Wraith JE (1996) Magnetic resonance imaging of the brain, neck and cervical spine in mild Hunter’s syndrome (mucopolysaccharidoses type II). Clin Radiol 51:719–723

    Article  PubMed  CAS  Google Scholar 

  72. Buyukgebiz B, Eroglu Y, Kovanlikaya I, Sen A, Buyukgebiz A (1995) Maroteaux-Lamy syndrome associated with growth hormone deficiency. J Pediatr Endocrinol Metab 8:305–307

    PubMed  CAS  Google Scholar 

  73. Murata R, Nakajima S, Tanaka A, Miyagi N, Matsuoka O, Kogame S, Inoue Y (1989) MR imaging of the brain in patients with mucopolysaccharidosis. AJNR Am J Neuroradiol 10:1165–1170

    PubMed  CAS  Google Scholar 

  74. Gabrielli O, Salvolini U, Maricotti M, Mariani MG, Coppa GV, Giorgi PL (1992) Cerebral MRI in two brothers with mucopolysaccharidosis type 1 and different genotypes. Neuroradiology 34:313–315

    Article  PubMed  CAS  Google Scholar 

  75. Shimoda-Matsubayashi S, Kuru Y, Sumie H, Ito T, Hattori N, Okuma Y, Mizuno Y (1990) MRI findings in the mild type of mucopolysaccharidosis II (Hunter’s syndrome). Neuroradiology 32:328–330

    Article  PubMed  CAS  Google Scholar 

  76. Rauch RA, Friloux LA 3rd, Lott I (1989) MR imaging of cavitary lesions in the brain with Hurler/Scheie. AJNR Am J Neuroradiol 10 (5 Suppl):S1–S3

    PubMed  CAS  Google Scholar 

  77. Lee CC, Chen CY, Chou TY, Chen FH, Lee CC, Zimmerman RA (1996) Cerebral manifestations of Pompe disease in an infant. AJNR Am J Neuroradiol 17:321–322

    PubMed  CAS  Google Scholar 

  78. Al-Essa MA, Bakheet SM, Patay ZJ, Powe JE, Ozand PT (1999) Normal fluorine-18-labelled 2-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging of the brain in Wolman disease. J Inherit Metab Dis 22:846–848

    Article  PubMed  CAS  Google Scholar 

  79. Yang YL, Sun F, Zhang Y et al (2006) Clinical and laboratory survey of 65 Chinese patients with Leigh syndrome. Chin Med J 118:373–377

    Google Scholar 

  80. Mannan AA, Sharma MC, Shrivastava P et al (2004) Leigh’s syndrome. Indian J Pediatr 71:1029–1033

    PubMed  CAS  Google Scholar 

  81. Crimi M, Papadimitriou A, Galbiati S et al (2004) A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethality. Pediatr Res 55:842–846

    Article  PubMed  Google Scholar 

  82. Filiano JJ, Goldenthal MJ, Mamourian AC, Hall CC, Marin-Garcia J (2002) Mitochondrial DNA depletion in Leigh syndrome. Pediatr Neurol 26:239–242

    Article  PubMed  Google Scholar 

  83. Cacic M, Wilichowski E, Mejaski-Bosnjak V et al (2001) Cytochrome c oxidase partial deficiency-associated Leigh disease presenting as an extrapyramidal syndrome. J Child Neurol 16:616–619

    PubMed  CAS  Google Scholar 

  84. Nagashima T, Mori M, Katayama K et al (1999) Adult Leigh syndrome with mitochondrial DNA mutation at 8993. Acta Neuropathol (Berl) 97:416–422

    Article  CAS  Google Scholar 

  85. Chu BC, Terae S, Takahashi C et al (1999) MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review. Neuroradiology 41:759–764

    Article  PubMed  CAS  Google Scholar 

  86. Nakagawa E, Hirano S, Yamanouchi H, Goto Y, Nonaka I, Takashima S (1994) Progressive brainstem and white matter lesions in Kearns-Sayre syndrome: a case report. Brain Dev 16:416–418

    Article  PubMed  CAS  Google Scholar 

  87. Kim IO, Kim JH, Kim WS, Hwang YS, Yeon KM, Han MC (1996) Mitochondrial myopathy-encephalopathy-lactic acidosis-and strokelike episodes (MELAS) syndrome: CT and MR findings in seven children. AJR Am J Roentgenol 166:641–645

    PubMed  CAS  Google Scholar 

  88. Wray SH, Provenzale JM, Johns DR, Thulborn KR (1995) MR of the brain in mitochondrial myopathy. AJNR Am J Neuroradiol 16:1167–1173

    PubMed  CAS  Google Scholar 

  89. Nolli M, Barbieri A, Pinna C, Pasetto A, Nicosia F (2005) Wernicke’s encephalopathy in a malnourished surgical patient: clinical features and magnetic resonance imaging. Acta Anaesthesiol 49:1566–1570

    Article  CAS  Google Scholar 

  90. Weidauer S, Nichtweiss M, Lanfermann H, Zanella FE (2003) Wernicke encephalopathy: MR findings and clinical presentation. Eur Radiol 13:1001–1009

    PubMed  Google Scholar 

  91. Oka M, Terae S, Kobayashi R et al (2001) Diffusion-weighted MR findings in a reversible case of acute Wernicke encephalopathy. Acta Neurol Scand 104:178–181

    Article  PubMed  CAS  Google Scholar 

  92. Antunez E, Estruch R, Cardenal C, Nicolas JM, Fernandez-Sola J, Urbano-Marquez A (1998) Usefulness of CT and MR imaging in the diagnosis of acute Wenicke’s encephalopathy. AJR Am J Roentgenol 171:1131–1137

    PubMed  CAS  Google Scholar 

  93. Hahn JS, Berquist W, Alcorn DM, Chamberlain L, Bass D (1998) Wernicke encephalopathy and beriberi during total parenteral nutrition attributable to multivitamin infusion shortage. Pediatrics 101:E10

    Article  PubMed  CAS  Google Scholar 

  94. Huang CC, Chu NS, Yen TC, Wai YY, Lu CS (2003) Dopamine transporter binding in Wilson’s disease. Can J Neurol Sci 30:163–167

    PubMed  Google Scholar 

  95. Wu JC, Huang CC, Jeng LB, Chu NS (2000) Correlation of neurological manifestations and MR images in a patient with Wilson’s disease after liver transplantation. Acta Neurol Scand 102:134–139

    Article  Google Scholar 

  96. Alanen A, Komu M, Penttinen M, Leino R (1999) Magnetic resonance imaging and proton spectroscopy in Wilson’s disease. Br J Radiol 72:749–756

    PubMed  CAS  Google Scholar 

  97. Takahashi W, Yoshii F, Shinohara Y (1996) Reversible magnetic resonance imaging lesions in Wilson’s disease: clinical-anatomical correlation. J Neuroimaging 6:246–248

    PubMed  CAS  Google Scholar 

  98. Huang CC, Chu NS (1998) Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson’s disease. Eur Neurol 39:32–37

    Article  PubMed  CAS  Google Scholar 

  99. Sener RN (1993) Wilson’s disease: MRI demonstration of cavitations in basal ganglia and thalami. Pediatr Radiol 23:157

    Article  PubMed  CAS  Google Scholar 

  100. Saatci I, Topcu M, Baltaoglu FF, Kose G, Yalaz K, Renda Y, Besim A (1997) Cranial MR findings in Wilson’s disease. Acta Radiol 38:250–258

    Article  PubMed  CAS  Google Scholar 

  101. Huang CC, Chu NS (1996) Wilson’s disease: resolution of MRI lesions following long-term oral zinc therapy. Acta Neurol Scand 93:215–218

    Article  PubMed  CAS  Google Scholar 

  102. Binesh N, Huda A, Thomas MA et al (2006) Hepatic encephalopathy: a neurochemical, and neurophysiological study. J Appl Clin Med Phys 7:86–96

    Article  PubMed  Google Scholar 

  103. Miyaoka T, Yasukawa R, Mihara T et al (2005) Fluid-attenuated inversion-recovery MR imaging in schizophrenia-associated with idiopathic unconjugated hyperbilirubinemia (Gilbert’s syndrome). Eur Psychiatry 20:327–331

    Article  PubMed  Google Scholar 

  104. Yilmaz Y, Ekinci G (2002) Thalamic involvement in a patient with kernikterus. Eur Radiol 12:1837–1839

    Article  PubMed  Google Scholar 

  105. Ozdoba C, Pfenninger J, Schroth G (1997) Initial and follow-up MRI in a case of early diagnosed Reye’s syndrome. Neuroradiology 39:495–498

    Article  PubMed  CAS  Google Scholar 

  106. Hoon AH Jr, Reinhardt EM, Kelley RI, Breiter SN, Morton DH, Naidu SB, Johnston MV (1997) Brain magnetic resonance imaging in suspected extrapyramidal cerebral palsy: observations in distinguishing genetic-metabolic from acquired causes. J Pediatr 131:240–245

    Article  PubMed  Google Scholar 

  107. Schonberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69–75

    Article  PubMed  CAS  Google Scholar 

  108. Majoie CB, Mourmans JM, Akkerman EM, Duran M, Poll-The BT (2004) Neonatal citrullemia: comparison of conventional MR, diffusion-weighted, and diffusion tensor findings. AJNR Am J Neuroradiol 25:32–35

    PubMed  Google Scholar 

  109. Takei Y, Akahane C, Ikeda S (2003) Osmotic demyelination syndrome: reversible MRI findings in bilateral cortical lesions. Intern Med 42:867–870

    PubMed  Google Scholar 

  110. Bourgouin P, Chalk C, Richardson J, Duong H, Vezina J (1995) Subcortical white matter lesions in osmotic demyelination syndrome. AJNR Am J Neuroradiol 16:1495–1497

    PubMed  CAS  Google Scholar 

  111. Weber U, Huppe T, Niehaus L (2000) CT and MRI in severe hypophosphataemia with central nervous system involvement. Neuroradiology 42:112–114

    Article  PubMed  CAS  Google Scholar 

  112. Porto L, Lanferman H, Moller-Hartmann W, Jacobi G, Zanella F (1999) Acute necrotising encephalopathy of childhood after exanthema subitum outside Japan or Taiwan. Neuroradiology 41:732–734

    Article  PubMed  CAS  Google Scholar 

  113. Neilson DE, Eiben RM, Waniewski S et al (2003) Autosomal dominant acute necrotizing encephalopathy. Neurology 61:226–230

    Article  PubMed  CAS  Google Scholar 

  114. Hartfield DS, Loewy JA, Yager JY (1999) Transient thalamic changes on MRI in a child with hypernatremia. Pediatr Neurol 20:60–62

    Article  PubMed  CAS  Google Scholar 

  115. Kobari M, Nogawa S, Sugimoto Y, Fukuuchi Y (1997) Familial idiopathic brain calcification with autosomal dominant inheritance. Neurology 48:645–649

    PubMed  CAS  Google Scholar 

  116. Nishio H, Kodama S, Matsuo T, Ichihashi M, Ito H, Fujiwara Y (1988) Cockayne syndrome: magnetic resonance images of the brain in a severe form with early onset. J Inherit Metab Dis 11:88–102

    Article  PubMed  CAS  Google Scholar 

  117. Rabi II, Zacharias JR, Millman S, Kusch P (1938) A new method of measuring nuclear magnetic moment. Phys Rev 53:318

    Article  CAS  Google Scholar 

  118. Solomon I (1955) Relaxation processes in a system of two spins. Phys Rev 99:559–565

    Article  CAS  Google Scholar 

  119. Bloembergen N, Purcell EM, Pound RV (1948) Relaxation effects in nuclear magnetic resonance absorption. Phys Rev 73:679–712

    Article  CAS  Google Scholar 

  120. Cavanagh J, Fairbrother WJ, Palmer AG III, Skelton NJ (1996) Protein NMR spectroscopy: principles and practice. Academic Press, London, p 587

    Google Scholar 

  121. Holmberg V, Lauronen L, Autti T, Santavuori P, Savukoski M, Uvebrant P, Hofman I, Peltonen L, Jarvela I (2000) Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology 55:579–581

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Helsinki Medical Imaging Center, Helsinki University Central Hospital, P.O. Box 340, 00029-HUS, Helsinki, Finland

    Taina Autti

  2. AstraZeneca R&D Molndal, Pepparedsleden 3, S-43183, Mölndal, Sweden

    Raimo Joensuu

  3. Department of Child Neurology, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland

    Laura Åberg

Authors
  1. Taina Autti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raimo Joensuu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Åberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Taina Autti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Autti, T., Joensuu, R. & Åberg, L. Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiology 49, 571–578 (2007). https://doi.org/10.1007/s00234-007-0220-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-007-0220-6

Keywords

Search

Navigation